報價延遲最少15分鐘:2024/11/16 09:08 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
189.64 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
8.61/16.38
|
|
企業價值
20.36B
|
| 資產負債 |
|
每股賬面淨值
115.74
|
| 現金流量 |
|
現金流量率
0.08
|
| 損益表 |
|
收益
326.66M
|
|
每股收益
96.79
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/11/16 09:08 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |